Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × pegfilgrastim × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Lymphoma 14 Neutropenia 9 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Neoplasms 6 Lymphoma, Follicular 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Triple Negative Breast Neoplasms 4 Hodgkin Disease 4 Chemotherapy-induced Neutropenia 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Colorectal Neoplasms 3 Breast Neoplasms, Male 3 Waldenstrom Macroglobulinemia 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, T-Cell, Peripheral 2 Lung Neoplasms 2

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 binimetinib 12 Paclitaxel 12 Introns 12 Interferon alpha-2 12 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 montanide ISA 51 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡